New pill targets hard-to-treat cancers in early trial
Disease control
Recruiting now
This early-phase trial tests an experimental oral drug called ST-01156 in about 171 adults with advanced solid tumors, including Ewing sarcoma, liver cancer, and bile duct cancer. The drug works by breaking down a protein inside cancer cells. The main goals are to find a safe dos…
Phase: PHASE1 • Sponsor: SEED Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC